Frontlight ResearchEarly access
Trial site
Newport News
- 5running trials
- 5closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease5 trials
- High blood pressure3 trials
- Asthma1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed2 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- AstraZeneca9 trials
- DalCor Pharmaceuticals1 trial
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026